MediWound (MDWD) Tops Q3 EPS by 14c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. LQDA
3. BAC
4. VSTM
5. UNH
6. GS
7. JPM
8. WDAY
9. FAST
10. FFAI

Go back to MediWound (MDWD) Tops Q3 EPS by 14c, Revenues Beat

MediWound Reports Third Quarter 2019 Financial Results

November 14, 2019 7:00 AM EST

Total revenues of $5.1 million, driven primarily by revenues from development services

Initiated U.S. NexoBrid expanded access treatment (NEXT) protocol, with plans on track for NexoBrid® BLA filing in the second quarter of 2020

Expected to initiate patient treatment in EscharEx® U.S. Phase 2 adaptive design study for Venus Leg Ulcers in the fourth quarter of 2019

Conference call begins today at 8:30 a.m. Eastern Time

YAVNE, Israel, Nov. 14, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated... More